Gapping down
News:
- PDSB -18.8% (stock offering)
- SAGE -13.5% (SAGE Therapeutics and Biogen (BIIB) report pivotal Phase 3 results for Zuranolone)
- VBLT -9.7% (provides an update on its ongoing OVAL Phase 3 study)
- PING -6.1% (stock offering)
- VRM -5.8% (convertible notes offering)
- DCRC -5.6% (Solid Power to list on NASDAQ through merger with Decarbonization Plus Acquisition Corporation III)
- EARN -4.9% (prices offering of 3.25 mln shares of common stock at $13.20 per share)
- ABR -4.5% (stock offering)
- ARE -4.3% (stock offering)
- CCCC -2.8% (stock offering)
- PTGX -2.7% (stock offering)
- FCX -2.2% (Copper futures down 3%)
- EQNR -2% (sets mid and long term goals in investor presentation)
- CBRL -1.7% (convertible notes offering)
- EHTH -1.5% (names new principal financial officer)
- RIG -1.2% (files mixed securities shelf offering; entered into $400 mln equity distribution agreement with Jefferies)
Analyst comments:
- FAST -3% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- PFG -0.8% (downgraded to Neutral from Overweight at Piper Sandler)